Ipsen, a €1.2 billion specialty pharmaceutical company with solid presence in neurology, endocrinology and uro-oncology, recently announced a decision to redeploy its US sales strategy. How should this announcement be perceived? Leading French-language life sciences...
FlyingKiteMedia released in August an article about Triana “as bridge to U.S. for overseas life science companies”. “The American business landscape can be daunting to an outsider, but it’s all in who you know. The Triana Group’s address...
